Do you want to join one of the fastest-growing molecular diagnostics startups and develop products that can affect the lives of millions?
BillionToOne, ranked at the top 5% of Y Combinator companies with $300M+ in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-invasive prenatal test that can directly screen an unborn baby and assess its risk for common and severe recessive gene disorders and chromosomal abnormalities, as well as fetal sex and fetal antigens, from a single tube of blood from the pregnant mother without paternal testing.
In 2023, BillionToOne launched two liquid biopsy products that will markedly improve oncology treatment and care. With Northstar Select™, clinicians will be able to select cancer therapies that will be most effective to each patient based on their individual genetic makeup. Northstar Response™ will enable clinicians to monitor a patient’s early response to these cancer therapies, by measuring minute changes in their ctDNA, which can reduce ineffective treatments and unwanted toxicity, lower costs, and substantially improve clinical outcomes.
We are looking for a Bioinformatics Associate, Prenatal to join our Clinical Operations team to create computational tools to analyze groundbreaking molecule diagnostics. This person will be responsible for developing bioinformatics pipelines and analyzing next-generation DNA sequencing data under the guidance of bioinformatics scientists.
This is a dynamic, start-up environment that requires adaptability and the ability to quickly learn and apply new concepts. The Bioinformatics Associate role is a full-time onsite position in Menlo Park, CA.
Responsibilities:
- Develop sophisticated and robust next-generation sequencing analysis pipelines under the guidance of a senior scientist
- Perform analysis of clinical bioinformatics data
- Assemble and analyze quality metrics from the clinical laboratory
- Collaborate with scientists and support new scientific insights
Requirements:
- BS or MS in Bioinformatics, Computational Biology, Computer Science, Bioengineering, Physics or related field
- 1-2 years of biology research experience (either during BS/MS or afterwards)
- Strong programming skills in Python, R or a similar language
- High mathematical and statistical aptitude
- Great attention to detail
Nice-To-Haves:
- Start-up experience
- Molecular biology (DNA purification, PCR, electrophoresis) or next-generation DNA sequencing laboratory experience
Benefits And Perks:
- Working with a team of ‘rockstars’ who bring out the best in everyone
- Open, transparent culture that includes weekly Town Hall meetings
- The ability to indirectly or directly change the lives of hundreds of thousands patients
- Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered at 80%
- Extremely generous Family Bonding Leave for new parents (16 weeks, paid at 100%)
- Retirement savings program including a 4% Company match
- Free daily on-site lunches provided from top eateries
- Latest and greatest hardware (laptop, lab equipment, facilities)
- A variety of perks on campus (state of the art gym, restaurant)
- Free on-site EV charging (compatible with all EVs, including Tesla)
At BillionToOne, we are proud to offer a combination of a (1) base pay range (actual amount offered is based experience and salary/equity options split that the candidate chooses) (2) generous equity options offering, on top of (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave etc.).
For this position, the base pay range is: $70,000-$80,000 per year.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Top Skills
What We Do
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules at the single-count level.